Immunity to fungi

Current Opinion in Immunology

Volumn 24, Issue 4, 2012, Pages 449-458

  LeibundGut Landmann, Salomé ^a   Wüthrich, Marcel ^b   Hohl, Tobias M ^c  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC PROTEINASE 2 VACCINE; BETA GLUCAN ANTIBODY; DECTIN 1; DECTIN 2; FUNGUS VACCINE; IMMUNOGLOBULIN M; INFLAMMASOME; INTERLEUKIN 1BETA; LECTIN RECEPTOR; LIVE VACCINE; RALS3P N VACCINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIGEN PRESENTATION; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CANDIDIASIS; CD4+ T LYMPHOCYTE; CRYPTOCOCCOSIS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; FUNGUS GROWTH; FUNGUS IMMUNITY; HUMAN; IMMUNE RESPONSE; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; NATURAL KILLER CELL; NONHUMAN; PNEUMOCYSTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN SYNTHESIS; REVIEW; T LYMPHOCYTE; TREATMENT RESPONSE; VACCINATION; VAGINA CANDIDIASIS;

ADAPTIVE IMMUNITY; ANIMALS; FUNGI; HUMANS; IMMUNITY, INNATE; LECTINS, C-TYPE; MYCOSES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER; TOLL-LIKE RECEPTORS;

EID: 84865294122     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2012.04.007     Document Type: Review

References (98)

1. Park B.J., Wannemuehler K.A., Marston B.J., Govender N., Pappas P.G., Chiller T.M. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009, 23:525-530.
2. Byrnes E.J., Bartlett K.H., Perfect J.R., Heitman J. Cryptococcus gattii: an emerging fungal pathogen infecting humans and animals. Microbes Infect 2011, 13:895-907.
3. Fisher M.C., Garner T.W., Walker S.F. Global emergence of Batrachochytrium dendrobatidis and amphibian chytridiomycosis in space, time, and host. Annu Rev Microbiol 2009, 63:291-310.
4. Frick W.F., Pollock J.F., Hicks A.C., Langwig K.E., Reynolds D.S., Turner G.G., Butchkoski C.M., Kunz T.H. An emerging disease causes regional population collapse of a common North American bat species. Science 2010, 329:679-682.
5. Liu M., Spellberg B., Phan Q.T., Fu Y., Fu Y., Lee A.S., Edwards J.E., Filler S.G., Ibrahim A.S. The endothelial cell receptor GRP78 is required for mucormycosis pathogenesis in diabetic mice. J Clin Invest 2010, 120:1914-1924.
6. Brown G.D. Innate antifungal immunity: the key role of phagocytes. Annu Rev Immunol 2011, 29:1-21.
7. Wüthrich M., Deepe G., Klein B. Adaptive immunity to fungi. Annu Rev Immunol 2012, 30:115-148.
8. Romani L. Immunity to fungal infections. Nat Rev Immunol 2011, 11:275-288.
9. Moalli F., Doni A., Deban L., Zelante T., Zagarella S., Bottazzi B., Romani L., Mantovani A., Garlanda C. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010, 116:5170-5180.
10. Moyes D.L., Runglall M., Murciano C., Shen C., Nayar D., Thavaraj S., Kohli A., Islam A., Mora-Montes H., Challacombe S.J., et al. A biphasic innate immune MAPK response discriminates between the yeast and hyphal forms of Candida albicans in epithelial cells. Cell Host Microbe 2010, 8:225-235.
11. Hohl T.M., Feldmesser M., Perlin D.S., Pamer E.G. Caspofungin modulates inflammatory responses to Aspergillus fumigatus through stage-specific effects on fungal beta-glucan exposure. J Infect Dis 2008, 198:176-185.
12. Biondo C., Signorino G., Costa A., Midiri A., Gerace E., Galbo R., Bellantoni A., Malara A., Beninati C., Teti G., et al. Recognition of yeast nucleic acids triggers a host-protective type I interferon response. Eur J Immunol 2011, 41:1969-1979.
13. Bourgeois C., Majer O., Frohner I.E., Lesiak-Markowicz I., Hildering K.S., Glaser W., Stockinger S., Decker T., Akira S., Muller M., et al. Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-beta signaling. J Immunol 2011, 186:3104-3112.
14. Kasperkovitz P.V., Cardenas M.L., Vyas J.M. TLR9 is actively recruited to Aspergillus fumigatus phagosomes and requires the N-terminal proteolytic cleavage domain for proper intracellular trafficking. J Immunol 2010, 185:7614-7622.
15. von Bernuth H., Picard C., Jin Z., Pankla R., Xiao H., Ku C.L., Chrabieh M., Mustapha I.B., Ghandil P., Camcioglu Y., et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science 2008, 321:691-696.
16. Plantinga T.S., Johnson M.D., Scott W.K., van de Vosse E., Velez Edwards D.R., Smith P.B., Alexander B.D., Yang J.C., Kremer D., Laird G.M., et al. Toll-like receptor 1 polymorphisms increase susceptibility to candidemia. J Infect Dis 2012, 205:934-943.
17. Bochud P.Y., Chien J.W., Marr K.A., Leisenring W.M., Upton A., Janer M., Rodrigues S.D., Li S., Hansen J.A., Zhao L.P., et al. Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. N Engl J Med 2008, 359:1766-1777.
18. Goodridge H.S., Reyes C.N., Becker C.A., Katsumoto T.R., Ma J., Wolf A.J., Bose N., Chan A.S., Magee A.S., Danielson M.E., et al. Activation of the innate immune receptor Dectin-1 upon formation of a 'phagocytic synapse'. Nature 2011, 472:471-475.
19. Strasser D., Neumann K., Bergmann H., Marakalala M.J., Guler R., Rojowska A., Hopfner K.P., Brombacher F., Urlaub H., Baier G., et al. Syk kinase-coupled C-type lectin receptors engage protein kinase C-sigma to elicit Card9 adaptor-mediated innate immunity. Immunity 2012, 36:32-42.
20. Gringhuis S.I., den Dunnen J., Litjens M., van der Vlist M., Wevers B., Bruijns S.C., Geijtenbeek T.B. Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 2009, 10:203-213.
21. Taylor P.R., Tsoni S.V., Willment J.A., Dennehy K.M., Rosas M., Findon H., Haynes K., Steele C., Botto M., Gordon S., et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. Nat Immunol 2007, 8:31-38.
22. Wells C.A., Salvage-Jones J.A., Li X., Hitchens K., Butcher S., Murray R.Z., Beckhouse A.G., Lo Y.L., Manzanero S., Cobbold C., et al. The macrophage-inducible C-type lectin, mincle, is an essential component of the innate immune response to Candida albicans. J Immunol 2008, 180:7404-7413.
23. Saijo S., Ikeda S., Yamabe K., Kakuta S., Ishigame H., Akitsu A., Fujikado N., Kusaka T., Kubo S., Chung S.H., et al. Dectin-2 recognition of alpha-mannans and induction of Th17 cell differentiation is essential for host defense against Candida albicans. Immunity 2010, 32:681-691.
24. Werner J.L., Metz A.E., Horn D., Schoeb T.R., Hewitt M.M., Schwiebert L.M., Faro-Trindade I., Brown G.D., Steele C. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol 2009, 182:4938-4946.
25. Saijo S., Fujikado N., Furuta T., Chung S.H., Kotaki H., Seki K., Sudo K., Akira S., Adachi Y., Ohno N., et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans. Nat Immunol 2007, 8:39-46.
26. Gorjestani S., Yu M., Tang B., Zhang D., Wang D., Lin X. Phospholipase Cgamma2 (PLCgamma2) is key component in Dectin-2 signaling pathway, mediating anti-fungal innate immune responses. J Biol Chem 2011, 286:43651-43659.
27. Gross O., Gewies A., Finger K., Schafer M., Sparwasser T., Peschel C., Forster I., Ruland J. Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity. Nature 2006, 442:651-656.
28. Sousa Mda G., Reid D.M., Schweighoffer E., Tybulewicz V., Ruland J., Langhorne J., Yamasaki S., Taylor P.R., Almeida S.R., Brown G.D. Restoration of pattern recognition receptor costimulation to treat chromoblastomycosis, a chronic fungal infection of the skin. Cell Host Microbe 2011, 9:436-443.
29. Gross O., Poeck H., Bscheider M., Dostert C., Hannesschlager N., Endres S., Hartmann G., Tardivel A., Schweighoffer E., Tybulewicz V., et al. Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence. Nature 2009, 459:433-436.
30. Hise A.G., Tomalka J., Ganesan S., Patel K., Hall B.A., Brown G.D., Fitzgerald K.A. An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe 2009, 5:487-497.
31. Joly S., Ma N., Sadler J.J., Soll D.R., Cassel S.L., Sutterwala F.S. Cutting edge: Candida albicans hyphae formation triggers activation of the Nlrp3 inflammasome. J Immunol 2009, 183:3578-3581.
32. Kumar H., Kumagai Y., Tsuchida T., Koenig P.A., Satoh T., Guo Z., Jang M.H., Saitoh T., Akira S., Kawai T. Involvement of the NLRP3 inflammasome in innate and humoral adaptive immune responses to fungal beta-glucan. J Immunol 2009, 183:8061-8067.
33. Lev-Sagie A., Prus D., Linhares I.M., Lavy Y., Ledger W.J., Witkin S.S. Polymorphism in a gene coding for the inflammasome component NALP3 and recurrent vulvovaginal candidiasis in women with vulvar vestibulitis syndrome. Am J Obstet Gynecol 2009, 200. 303e301-303e306.
34. Tomalka J., Ganesan S., Azodi E., Patel K., Majmudar P., Hall B.A., Fitzgerald K.A., Hise A.G. A novel role for the NLRC4 inflammasome in mucosal defenses against the fungal pathogen Candida albicans. PLoS Pathog 2011, 7:e1002379.
35. van de Veerdonk F.L., Joosten L.A., Devesa I., Mora-Montes H.M., Kanneganti T.D., Dinarello C.A., van der Meer J.W., Gow N.A., Kullberg B.J., Netea M.G. Bypassing pathogen-induced inflammasome activation for the regulation of interleukin-1beta production by the fungal pathogen Candida albicans. J Infect Dis 2009, 199:1087-1096.
36. Gringhuis S.I., Kaptein T.M., Wevers B.A., Theelen B., van der Vlist M., Boekhout T., Geijtenbeek T.B. Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1beta via a noncanonical caspase-8 inflammasome. Nat Immunol 2012, 13:246-254.
37. Ramirez-Ortiz Z.G., Lee C.K., Wang J.P., Boon L., Specht C.A., Levitz S.M. A nonredundant role for plasmacytoid dendritic cells in host defense against the human fungal pathogen Aspergillus fumigatus. Cell Host Microbe 2011, 9:415-424.
38. Kawakami K., Kinjo Y., Yara S., Koguchi Y., Uezu K., Nakayama T., Taniguchi M., Saito A. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans. Infect Immun 2001, 69:213-220.
39. Cohen N.R., Tatituri R.V., Rivera A., Watts G.F., Kim E.Y., Chiba A., Fuchs B.B., Mylonakis E., Besra G.S., Levitz S.M., et al. Innate recognition of cell wall beta-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 2011, 10:437-450.
40. Boyle K.B., Gyori D., Sindrilaru A., Scharffetter-Kochanek K., Taylor P.R., Mocsai A., Stephens L.R., Hawkins P.T. Class IA phosphoinositide 3-kinase beta and delta regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae. J Immunol 2011, 186:2978-2989.
41. Li X., Utomo A., Cullere X., Choi M.M., Milner D.A., Venkatesh D., Yun S.H., Mayadas T.N. The beta-glucan receptor Dectin-1 activates the integrin Mac-1 in neutrophils via Vav protein signaling to promote Candida albicans clearance. Cell Host Microbe 2011, 10:603-615.
42. Romani L., Fallarino F., De Luca A., Montagnoli C., D'Angelo C., Zelante T., Vacca C., Bistoni F., Fioretti M.C., Grohmann U., et al. Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. Nature 2008, 451:211-215.
43. Bianchi M., Hakkim A., Brinkmann V., Siler U., Seger R.A., Zychlinsky A., Reichenbach J. Restoration of NET formation by gene therapy in CGD controls aspergillosis. Blood 2009, 114:2619-2622.
44. Urban C.F., Ermert D., Schmid M., Abu-Abed U., Goosmann C., Nacken W., Brinkmann V., Jungblut P.R., Zychlinsky A. Neutrophil extracellular traps contain calprotectin, a cytosolic protein complex involved in host defense against Candida albicans. PLoS Pathog 2009, 5:e1000639.
45. Bruns S., Kniemeyer O., Hasenberg M., Aimanianda V., Nietzsche S., Thywissen A., Jeron A., Latge J.P., Brakhage A.A., Gunzer M. Production of extracellular traps against Aspergillus fumigatus in vitro and in infected lung tissue is dependent on invading neutrophils and influenced by hydrophobin RodA. PLoS Pathog 2010, 6:e1000873.
46. Menegazzi R., Decleva E., Dri P. Killing by neutrophil extracellular traps: fact or folklore?. Blood 2012, 119:1214-1216.
47. Greenblatt M.B., Aliprantis A., Hu B., Glimcher L.H. Calcineurin regulates innate antifungal immunity in neutrophils. J Exp Med 2010, 207:923-931.
48. Reeves E.P., Lu H., Jacobs H.L., Messina C.G., Bolsover S., Gabella G., Potma E.O., Warley A., Roes J., Segal A.W. Killing activity of neutrophils is mediated through activation of proteases by K+ flux. Nature 2002, 416:291-297.
49. Vethanayagam R.R., Almyroudis N.G., Grimm M.J., Lewandowski D.C., Pham C.T., Blackwell T.S., Petraitiene R., Petraitis V., Walsh T.J., Urban C.F., et al. Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. PLoS ONE 2011, 6:e28149.
50. Winters M.S., Chan Q., Caruso J.A., Deepe G.S. Metallomic analysis of macrophages infected with Histoplasma capsulatum reveals a fundamental role for zinc in host defenses. J Infect Dis 2010, 202:1136-1145.
51. Hohl T.M., Rivera A., Lipuma L., Gallegos A., Shi C., Mack M., Pamer E.G. Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection. Cell Host Microbe 2009, 6:470-481.
52. Wüthrich M., Ersland K., Galles K.J., Sullivan T.D., Klein B.S. Fungi subvert vaccine T cell priming at the respiratory mucosa by preventing chemokine-induced influx of inflammatory monocytes. Immunity 2012, 36:680-692.
53. Ersland K., Wüthrich M., Klein B.S. Dynamic interplay among monocyte-derived, dermal, and resident lymph node dendritic cells during the generation of vaccine immunity to fungi. Cell Host Microbe 2010, 7:474-487.
54. Wüthrich M., Hung C.Y., Gern B.H., Pick-Jacobs J.C., Galles K.J., Filutowicz H.I., Cole G.T., Klein B.S. A TCR transgenic mouse reactive with multiple systemic dimorphic fungi. J Immunol 2011, 187:1421-1431.
55. Rivera A., Ro G., Van Epps H.L., Simpson T., Leiner I., Sant'Angelo D.B., Pamer E.G. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. Immunity 2006, 25:665-675.
56. Conti H.R., Shen F., Nayyar N., Stocum E., Sun J.N., Lindemann M.J., Ho A.W., Hai J.H., Yu J.J., Jung J.W., et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206:299-311.
57. Kagami S., Rizzo H.L., Kurtz S.E., Miller L.S., Blauvelt A. IL-23 and IL-17A, but not IL-12 and IL-22, are required for optimal skin host defense against Candida albicans. J Immunol 2010, 185:5453-5462.
58. Deepe G.S., Gibbons R.S. Interleukins 17 and 23 influence the host response to Histoplasma capsulatum. J Infect Dis 2009, 200:142-151.
59. Rudner X.L., Happel K.I., Young E.A., Shellito J.E. Interleukin-23 (IL-23)-IL-17 cytokine axis in murine Pneumocystis carinii infection. Infect Immun 2007, 75:3055-3061.
60. Werner J.L., Gessner M.A., Lilly L.M., Nelson M.P., Metz A.E., Horn D., Dunaway C.W., Deshane J., Chaplin D.D., Weaver C.T., et al. Neutrophils produce interleukin 17A (IL-17A) in a dectin-1- and IL-23-dependent manner during invasive fungal infection. Infect Immun 2011, 79:3966-3977.
61. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
62. Wüthrich M., Gern B., Hung C.Y., Ersland K., Rocco N., Pick-Jacobs J., Galles K., Filutowicz H., Warner T., Evans M., et al. Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest 2011, 121:554-568.
63. Zelante T., De Luca A., Bonifazi P., Montagnoli C., Bozza S., Moretti S., Belladonna M.L., Vacca C., Conte C., Mosci P., et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol 2007, 37:2695-2706.
64. Loures F.V., Pina A., Felonato M., Calich V.L. TLR2 is a negative regulator of Th17 cells and tissue pathology in a pulmonary model of fungal infection. J Immunol 2009, 183:1279-1290.
65. Kroetz D.N., Deepe G.S. CCR5 dictates the equilibrium of proinflammatory IL-17+ and regulatory Foxp3+ T cells in fungal infection. J Immunol 2010, 184:5224-5231.
66. Pandiyan P., Conti H.R., Zheng L., Peterson A.C., Mathern D.R., Hernandez-Santos N., Edgerton M., Gaffen S.L., Lenardo M.J. CD4(+)CD25(+)Foxp3(+) regulatory T cells promote Th17 cells in vitro and enhance host resistance in mouse Candida albicans Th17 cell infection model. Immunity 2011, 34:422-434.
67. Hung C.Y., Gonzalez A., Wüthrich M., Klein B.S., Cole G.T. Vaccine immunity to coccidioidomycosis occurs by early activation of three signal pathways of T helper cell response (Th1, Th2, and Th17). Infect Immun 2011, 79:4511-4522.
68. LeibundGut-Landmann S., Gross O., Robinson M.J., Osorio F., Slack E.C., Tsoni S.V., Schweighoffer E., Tybulewicz V., Brown G.D., Ruland J., et al. Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 2007, 8:630-638.
69. Rivera A., Hohl T.M., Collins N., Leiner I., Gallegos A., Saijo S., Coward J.W., Iwakura Y., Pamer E.G. Dectin-1 diversifies Aspergillus fumigatus-specific T cell responses by inhibiting T helper type 1 CD4 T cell differentiation. J Exp Med 2011, 208:369-381.
70. Robinson M.J., Osorio F., Rosas M., Freitas R.P., Schweighoffer E., Gross O., Verbeek J.S., Ruland J., Tybulewicz V., Brown G.D., et al. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 2009, 206:2037-2051.
71. Wüthrich M., Filutowicz H.I., Warner T., Deepe G.S., Klein B.S. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 2003, 197:1405-1416.
72. Xue J., Chen X., Selby D., Hung C.Y., Yu J.J., Cole G.T. A genetically engineered live attenuated vaccine of Coccidioides posadasii protects BALB/c mice against coccidioidomycosis. Infect Immun 2009, 77:3196-3208.
73. Nanjappa S.G., Heninger E., Wüthrich M., Sullivan T., Klein B. Protective antifungal memory CD8+ T cells are maintained in the absence of CD4+ T cell help and cognate antigen in mice. J Clin Invest 2012, 122:987-999.
74. Lin L., Ibrahim A.S., Xu X., Farber J.M., Avanesian V., Baquir B., Fu Y., French S.W., Edwards J.E., Spellberg B. Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 2009, 5:e1000703.
75. Diaz-Arevalo D., Bagramyan K., Hong T.B., Ito J.I., Kalkum M. CD4+ T cells mediate the protective effect of the recombinant Asp f3-based anti-aspergillosis vaccine. Infect Immun 2011, 79:2257-2266.
76. Bär E., Gladiator A., Bastidas S., Roschitzki B., Acha-Orbea H., Oxenius A., LeibundGut-Landmann S. A novel T helper cell epitope of Candida albicans mediates protection from fungal infection. J Immunol 2012, published ahead of print April 23. 10.4049/jimmunol.1200594.
77. Stuehler C., Khanna N., Bozza S., Zelante T., Moretti S., Kruhm M., Lurati S., Conrad B., Worschech E., Stevanovic S., et al. Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 2011, 117:5881-5891.
78. Rapaka R.R., Ricks D.M., Alcorn J.F., Chen K., Khader S.A., Zheng M., Plevy S., Bengten E., Kolls J.K. Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. J Exp Med 2010, 207:2907-2919.
79. Sandini S., La Valle R., Deaglio S., Malavasi F., Cassone A., De Bernardis F. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine. FEMS Immunol Med Microbiol 2011, 62:215-224.
80. Bromuro C., Romano M., Chiani P., Berti F., Tontini M., Proietti D., Mori E., Torosantucci A., Costantino P., Rappuoli R., et al. Beta-glucan-CRM197 conjugates as candidates antifungal vaccines. Vaccine 2010, 28:2615-2623.
81. Xin H., Dziadek S., Bundle D.R., Cutler J.E. Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis. Proc Natl Acad Sci USA 2008, 105:13526-13531.
82. Conti H.R., Baker O., Freeman A.F., Jang W.S., Holland S.M., Li R.A., Edgerton M., Gaffen S.L. New mechanism of oral immunity to mucosal candidiasis in hyper-IgE syndrome. Mucosal Immunol 2011, 4:448-455.
83. Avci F.Y., Li X., Tsuji M., Kasper D.L. A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med 2011, 17:1602-1609.
84. Huang H., Ostroff G.R., Lee C.K., Specht C.A., Levitz S.M. Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles. MBio 2010, 1.
85. Ferwerda B., Ferwerda G., Plantinga T.S., Willment J.A., van Spriel A.B., Venselaar H., Elbers C.C., Johnson M.D., Cambi A., Huysamen C., et al. Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009, 361:1760-1767.
86. Plantinga T.S., van der Velden W.J., Ferwerda B., van Spriel A.B., Adema G., Feuth T., Donnelly J.P., Brown G.D., Kullberg B.J., Blijlevens N.M., et al. Early stop polymorphism in human DECTIN-1 is associated with increased candida colonization in hematopoietic stem cell transplant recipients. Clin Infect Dis 2009, 49:724-732.
87. Cunha C., Di Ianni M., Bozza S., Giovannini G., Zagarella S., Zelante T., D'Angelo C., Pierini A., Pitzurra L., Falzetti F., et al. Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. Blood 2010, 116:5394-5402.
88. Chai L.Y., de Boer M.G., van der Velden W.J., Plantinga T.S., van Spriel A.B., Jacobs C., Halkes C.J., Vonk A.G., Blijlevens N.M., van Dissel J.T., et al. The Y238X stop codon polymorphism in the human beta-glucan receptor dectin-1 and susceptibility to invasive aspergillosis. J Infect Dis 2011, 203:736-743.
89. Glocker E.O., Hennigs A., Nabavi M., Schaffer A.A., Woellner C., Salzer U., Pfeifer D., Veelken H., Warnatz K., Tahami F., et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009, 361:1727-1735.
90. Holland S.M. Chronic granulomatous disease. Clin Rev Allergy Immunol 2010, 38:3-10.
91. de Beaucoudrey L., Samarina A., Bustamante J., Cobat A., Boisson-Dupuis S., Feinberg J., Al-Muhsen S., Janniere L., Rose Y., de Suremain M., et al. Revisiting human IL-12Rbeta1 deficiency: a survey of 141 patients from 30 countries. Medicine (Baltimore) 2010, 89:381-402.
92. Holland S.M., DeLeo F.R., Elloumi H.Z., Hsu A.P., Uzel G., Brodsky N., Freeman A.F., Demidowich A., Davis J., Turner M.L., et al. STAT3 mutations in the hyper-IgE syndrome. N Engl J Med 2007, 357:1608-1619.
93. Minegishi Y., Saito M., Tsuchiya S., Tsuge I., Takada H., Hara T., Kawamura N., Ariga T., Pasic S., Stojkovic O., et al. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature 2007, 448:1058-1062.
94. Liu L., Okada S., Kong X.F., Kreins A.Y., Cypowyj S., Abhyankar A., Toubiana J., Itan Y., Audry M., Nitschke P., et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J Exp Med 2011, 208:1635-1648.
95. van de Veerdonk F.L., Plantinga T.S., Hoischen A., Smeekens S.P., Joosten L.A., Gilissen C., Arts P., Rosentul D.C., Carmichael A.J., Smits-van der Graaf C.A., et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 2011, 365:54-61.
96. Puel A., Cypowyj S., Bustamante J., Wright J.F., Liu L., Lim H.K., Migaud M., Israel L., Chrabieh M., Audry M., et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011, 332:65-68.
97. Kisand K., Boe Wolff A.S., Podkrajsek K.T., Tserel L., Link M., Kisand K.V., Ersvaer E., Perheentupa J., Erichsen M.M., Bratanic N., et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines. J Exp Med 2010, 207:299-308.
98. Puel A., Doffinger R., Natividad A., Chrabieh M., Barcenas-Morales G., Picard C., Cobat A., Ouachee-Chardin M., Toulon A., Bustamante J., et al. Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010, 207:291-297.